{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:31:57Z","timestamp":1793385117589,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122369","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:30:05Z","timestamp":1786404605000},"page":"122369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy"],"prefix":"10.1016","volume":"414","author":[{"given":"Yves Martins","family":"Varela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cavalcanti-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovan Menezes","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Falchi-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"dos Santos Fernandes Barbalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raynara Bolcont","family":"de Oliveira Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Moura Medina","family":"Gurgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Carvalho","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e2mela Milena","family":"de Lima Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaike Thi\u00ea","family":"da Costa Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Muniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Rocha N\u00f3brega","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Felipe Dantas","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Cavalcante","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Santos","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Igor Torquato Cardoso","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadne Cruz","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Draulio Barros","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Palhano-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Fernandes-Osterhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Galv\u00e3o-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122369_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0952-8180(94)00001-K","article-title":"The post-anesthesia recovery score revisited","volume":"7","author":"Aldrete","year":"1995","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.jad.2026.122369_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review and meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122369_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1037\/0003-066X.61.4.271","article-title":"Evidence-based practice in psychology","volume":"61","author":"American Psychological Association Presidential Task Force on Evidence-Based Practice","year":"2006","journal-title":"Am. Psychol."},{"key":"10.1016\/j.jad.2026.122369_bb0020","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine\u2019s antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jad.2026.122369_bb0025","series-title":"Cognitive Behavior Therapy: Basics and beyond","author":"Beck","year":"2021"},{"key":"10.1016\/j.jad.2026.122369_bb0030","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.jad.2026.122369_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.jad.2026.122369_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313070","article-title":"Augmentative pharmacological strategies in treatment-resistant major depression: a comprehensive review","volume":"22","author":"Caldiroli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2026.122369_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120877","article-title":"Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: the role of baseline C-reactive protein","volume":"397","author":"Cavalcanti-Ribeiro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122369_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-assisted psychotherapy\u2014a systematic review of associated psychological interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122369_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0253-7176.127258","article-title":"Acute antidepressant effects of intramuscular versus intravenous ketamine","volume":"36","author":"Chilukuri","year":"2014","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.jad.2026.122369_bb0060","series-title":"Psychedelic Psychotherapy: A User-Friendly Guide for Psychedelic Drug-Assisted Psychotherapy","author":"Coleman","year":"2017"},{"key":"10.1016\/j.jad.2026.122369_bb0065","article-title":"A clinical protocol for group-based ketamine-assisted therapy in a community of practice: the roots to thrive model","volume":"16","author":"Dames","year":"2025","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.jad.2026.122369_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","article-title":"Ketamine assisted psychotherapy (KAP): patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy","volume":"51","author":"Dore","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jad.2026.122369_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/JPR.S360733","article-title":"Ketamine assisted psychotherapy: a systematic narrative review of the literature","volume":"15","author":"Drozdz","year":"2022","journal-title":"J. Pain Res."},{"key":"10.1016\/j.jad.2026.122369_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2026.122369_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-025-02091-6","article-title":"Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression","author":"Falchi-Carvalho","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122369_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.54843","article-title":"Psychological therapy quantity and depressive symptom reduction in psychedelic-assisted therapy: A systematic review and meta-analysis","volume":"9","author":"Florineth","year":"2026","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.122369_bb0095","author":"Food and Drug Administration"},{"key":"10.1016\/j.jad.2026.122369_bb0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.biopsych.2013.12.010","article-title":"Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report","volume":"76","author":"G\u00e1lvez","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0105","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jagp.2017.06.007","article-title":"Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression","volume":"25","author":"George","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0110","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.biopsych.2010.11.031","article-title":"Dose- and exposure-response to ketamine in depression","volume":"70","author":"Glue","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb2110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.rbp.2012.03.005","article-title":"Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample","volume":"34","author":"Gomes-Oliveira","year":"2012","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112629","article-title":"Ketamine as a mental health treatment: are acute psychoactive effects associated with outcomes? A systematic review","volume":"392","author":"Grabski","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2026.122369_bb0120","article-title":"A qualitative study of patients\u2019 experience of ketamine treatment for depression: the \u2018ketamine and me\u2019 project","volume":"4","author":"Griffiths","year":"2021","journal-title":"J. Affect. Disord. Rep."},{"key":"10.1016\/j.jad.2026.122369_bb2120","series-title":"Acceptance and Commitment Therapy: The Process and Practice of Mindful Change","author":"Hayes","year":"2011"},{"key":"10.1016\/j.jad.2026.122369_bb0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s43440-024-00636-y","article-title":"Fast-acting antidepressant-like effects of ketamine in aged male rats","volume":"76","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jad.2026.122369_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20451253261456405","article-title":"Patient-centred education for ketamine and esketamine therapies in mood disorders","volume":"16","author":"Kachlik","year":"2026","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122369_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/02698811251350267","article-title":"Urological symptoms following ketamine treatment for psychiatric disorders: a systematic review","author":"Kerr-Gaffney","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122369_bb0140","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.53","article-title":"Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review","volume":"9","author":"Kew","year":"2023","journal-title":"BJPsych Open"},{"key":"10.1016\/j.jad.2026.122369_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/02791072.1997.10400185","article-title":"Ketamine psychedelic therapy (KPT): a review of the results of ten years of research","volume":"29","author":"Krupitsky","year":"1997","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jad.2026.122369_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122369_bb0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jad.2025.01.054","article-title":"Hepatic adverse events associated with ketamine and esketamine: a population-based disproportionality analysis","volume":"374","author":"Kwan","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122369_bb0160","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.2017.13737","article-title":"Is cognitive behavioral therapy the gold standard for psychotherapy? The need for plurality in treatment and research","volume":"318","author":"Leichsenring","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.122369_bb0170","series-title":"O despertar do tigre: curando o trauma","author":"Levine","year":"1999"},{"key":"10.1016\/j.jad.2026.122369_bb0175","series-title":"Uma voz sem palavras: como o corpo libera o trauma e restaura o bem-estar","author":"Levine","year":"2012"},{"key":"10.1016\/j.jad.2026.122369_bb0180","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jad.2026.122369_bb0185","first-page":"1","article-title":"Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomized double-blind active-controlled trial","author":"Loo","year":"2023","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122369_bb0195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpsychires.2024.06.020","article-title":"Rapid and long-lasting effects of subcutaneous esketamine on suicidality: an open-label study in patients with treatment-resistant depression","volume":"176","author":"Lopes","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122369_bb0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.genhosppsych.2026.04.005","article-title":"Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: a systematic review","volume":"100","author":"Lovell","year":"2026","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jcbs.2019.10.003","article-title":"Toward a contextual psychedelic-assisted therapy: perspectives from acceptance and commitment therapy and contextual behavioral science","volume":"14","author":"Luoma","year":"2019","journal-title":"J. Contextual Behav. Sci."},{"key":"10.1016\/j.jad.2026.122369_bb0210","article-title":"Mystical experience induced by esketamine treatment: a real-world observational study","author":"Mallevays","year":"2026","journal-title":"medRxiv"},{"key":"10.1016\/j.jad.2026.122369_bb0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2019.12.023","article-title":"The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: a systematic review","volume":"264","author":"Mathai","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122369_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.868103","article-title":"Toward synergies of ketamine and psychotherapy","volume":"13","author":"Mathai","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122369_bb0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0230","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2025.04.041","article-title":"Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: evidence from a help-seeking sample","volume":"381","author":"Moore","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122369_bb0240","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0245","article-title":"An integrative approach to ketamine therapy may enhance multiple dimensions of efficacy: improving therapeutic outcomes with treatment resistant depression","volume":"12","author":"Muscat","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122369_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20503245251380511","article-title":"A lexicon for psychedelic research and treatment","volume":"11","author":"Nutt","year":"2025","journal-title":"Drug Sci. Policy Law"},{"key":"10.1016\/j.jad.2026.122369_bb0255","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122369_bb0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jad.2024.09.141","article-title":"Repeated subcutaneous esketamine on treatment-resistant depression: an open-label dose titration study","volume":"369","author":"Palhano-Fontes","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122369_bb0265","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0270","series-title":"The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-Regulation","author":"Porges","year":"2011"},{"key":"10.1016\/j.jad.2026.122369_bb0275","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2542-3932.211589","volume":"2","author":"Pradhan","year":"2017","journal-title":"Asia Pac. J. Clin. Trials Nerv. Syst. Dis."},{"key":"10.1016\/j.jad.2026.122369_bb0280","article-title":"A review of nonanesthetic uses of ketamine","volume":"2020","author":"Pribish","year":"2020","journal-title":"Anesthesiol. Res. Pract."},{"key":"10.1016\/j.jad.2026.122369_bb0285","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa2304145","article-title":"Esketamine nasal spray versus quetiapine for treatment-resistant depression","volume":"389","author":"Reif","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.122369_bb0290","series-title":"Cognitive Processing Therapy for PTSD: A Comprehensive Manual","author":"Resick","year":"2016"},{"key":"10.1016\/j.jad.2026.122369_bb0300","article-title":"Ketamine-assisted group psychotherapy integrating cognitive processing therapy to address identity-based trauma: a pilot study","volume":"16","author":"Sevelius","year":"2026","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122369_bb0305","series-title":"Eye Movement Desensitization and Reprocessing (EMDR) Therapy: Basic Principles, Protocols, and Procedures","author":"Shapiro","year":"2017"},{"key":"10.1016\/j.jad.2026.122369_bb0310","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamapsychiatry.2026.0612","article-title":"Ketamine infusions and rapid reduction of suicidal and depressive symptoms in major depressive episode: A systematic review and Meta-analysis","volume":"83","author":"Shim","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122369_bb0315","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpsychires.2021.03.009","article-title":"Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: a systematic review","volume":"137","author":"Siegel","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122369_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychsport.2024.102729","article-title":"Effectiveness of an affect-adjusted, supervised, multimodal, online and home-based exercise group protocol for major depression: A randomized controlled trial","volume":"76","author":"Tavares","year":"2025","journal-title":"Psychol. Sport Exerc."},{"key":"10.1016\/j.jad.2026.122369_bb0325","article-title":"Psychophysiological responses to group cognitive-behavioral therapy in depressive patients","author":"Varela","year":"2021","journal-title":"Curr. Psychol."},{"key":"10.1016\/j.jad.2026.122369_bb0330","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-025-02188-5","article-title":"Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics","author":"Varela","year":"2026","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.122369_bb0335","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ijnp\/pyab039","article-title":"Pharmacodynamic interactions between ketamine and psychiatric medications used in the treatment of depression: a systematic review","volume":"24","author":"Veraart","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122369_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2026.102706","article-title":"Ketamine-assisted psychotherapies for mental disorders: a historical overview and systematic review","volume":"124","author":"Veraart","year":"2026","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2026.122369_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15010150","article-title":"Patients\u2019 voices on ketamine for treatment-resistant depression: a narrative review of qualitative perspectives","volume":"15","author":"Walaszek","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jad.2026.122369_bb0350","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2026.122369_bb0355","series-title":"Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications","year":"2019"},{"key":"10.1016\/j.jad.2026.122369_bb0365","article-title":"A case of hepatotoxicity induced by therapeutic ketamine use for sedation","volume":"2024","author":"Yoo","year":"2024","journal-title":"Case Rep. Crit. Care"},{"key":"10.1016\/j.jad.2026.122369_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf027","article-title":"Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study","volume":"28","author":"Zaki","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122369_bb0380","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272601222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272601222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:51:08Z","timestamp":1793382668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272601222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":74,"alternative-id":["S016503272601222X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122369","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122369"}}